Unlike 68Ga-PSMA-11 PET/CT, which is predominately excreted via the urinary tract, 18F-PSMA-1007 demonstrates lower renal clearance resulting in increased physiological bone uptake that may not correlate with metastatic disease. This evidence concerns the gene FOLH1 and metastatic neoplasm.